Jason Zhu, MD, a medical oncologist at Levine Cancer Institute, part of Atrium Health, discusses factors he considers when choosing treatment for patients with lymph node–positive prostate cancer after prostatectomy.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.